FHIR Provenance vs AuditEvent: GxP Traceability Matrix
FHIR Provenance vs AuditEvent for GxP in 2026: a scenario crosswalk of 11 events, version and signature limits, Part 11 and Annex 11 context, retention anchors, and four test ratios.
Back to Articles
Articles tagged with “annex-11”
GxP AI Compliance: Guardrails for Inspection Readiness
How RAG grounding, audit trails, and data isolation can support 21 CFR Part 11 and Annex 11 compliance and inspection readiness for GxP AI in pharma.
Electronic Batch Records in Biotech: GxP & Software Guide
Explore GxP requirements for Electronic Batch Records (EBR) in biotech. Covers FDA 21 CFR Part 11 compliance, validation, and current software options.
DocuSign in Pharma: A Guide to 21 CFR Part 11 Compliance
An analysis of how Docusign (formerly DocuSign) is used for electronic signatures in pharma and life sciences. Learn how it can meet FDA 21 CFR Part 11 compliance with its Life Sciences modules and IAM platform, updated for 2026.
21 CFR Part 11: IT Guide to Electronic Records & Signatures
Updated 2026 guide for IT on 21 CFR Part 11. Covers FDA CSA guidance, AI compliance, electronic records & signatures, system validation, audit trails & data integrity
Navigating Regulatory Compliance in RTSM Systems for Clinical Trials
A comprehensive guide to regulatory requirements and best practices for implementing compliant Randomization and Trial Supply Management (RTSM) systems in clinical trials, covering FDA, EMA, and global standards.